Align Technology (NASDAQ:ALGN) Releases Earnings Results, Misses Estimates By $0.47 EPS

Align Technology (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday. The medical equipment provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.43 by ($0.47), Zacks reports. Align Technology had a net margin of 11.15% and a return on equity of 13.99%. Align Technology updated its Q1 2025 guidance to EPS.

Align Technology Trading Up 0.7 %

Align Technology stock opened at $216.36 on Thursday. The company’s 50-day moving average price is $222.19 and its two-hundred day moving average price is $226.22. The stock has a market cap of $16.15 billion, a price-to-earnings ratio of 36.92, a PEG ratio of 4.80 and a beta of 1.67. Align Technology has a 52 week low of $196.09 and a 52 week high of $335.40.

Analysts Set New Price Targets

A number of brokerages have commented on ALGN. Piper Sandler decreased their target price on Align Technology from $285.00 to $275.00 and set an “overweight” rating for the company in a research note on Thursday, October 24th. Robert W. Baird reduced their price objective on Align Technology from $325.00 to $276.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Stifel Nicolaus dropped their target price on Align Technology from $285.00 to $275.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. Jefferies Financial Group reduced their price target on shares of Align Technology from $285.00 to $260.00 and set a “buy” rating for the company in a report on Thursday, January 23rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $271.70.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.